Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GoBBson Aug 13, 2021 9:51am
63 Views
Post# 33700044

RE:RE:RE:RE:RE:RE:RE:TOMMY THE DUMMY

RE:RE:RE:RE:RE:RE:RE:TOMMY THE DUMMY
Aldo, I like many wanted to believe, to be part of a great Canadian success story. I believed in the science of PPPS, I believed in PL and PLI. But time and time again they failed us to the point we were wiped out by them and then they had the f'n nerve to ask us to put in more $$$. That was the end for me.  I'm very happy Ryplazim was approved and patients will get this amazing therapy. But I have no illusions of what happened, we were wrecked by the very people that told us they had our back, that PLI was worth billions, that PPPS, Ryplazim and 4050 were the second coming and they had many analyst projections to back it all up. If you hang on here I understand, its hard to let go. I do wish you good luck.
<< Previous
Bullboard Posts
Next >>